Cyclic AMP inhibits p38 activation via CREB-induced dynein light chain

Molecular and Cellular Biology

Volumn 26, Issue 4, 2006, Pages 1223-1234

  Zhang, Jiyan ^a   Bui, Truc N ^a   Xiang, Jialing ^b   Lin, Anning ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b ILLINOIS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DYNEIN ADENOSINE TRIPHOSPHATASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CONTROLLED STUDY; DLC GENE; EMBRYO; ENZYME ACTIVATION; GENE; HUMAN; HUMAN CELL; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELL LINE; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DROSOPHILA PROTEINS; ENZYME ACTIVATION; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MODELS, BIOLOGICAL; NF-KAPPA B; NIH 3T3 CELLS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS; RNA INTERFERENCE; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 32044463169     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.26.4.1223-1234.2006     Document Type: Article

References (76)

1. Ahn, S., M. Olive, S. Aggarwal, D. Krylov, D. D. Ginty, and C. Vinson. 1998. A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos. Mol. Cell. Biol. 18:967-977.
2. Best, J. L., C. A. Amezcua, B. Mayr, L. Flechner, C. M. Murawsky, B. Emerson, T. Zor, K. H. Gardner, and M. Montminy. 2004. Identification of small-molecule antagonists that inhibit an activator: coactivator interaction. Proc. Natl. Acad. Sci. USA 101:17622-17627.
3. Birnbaumer, L. 1992. Receptor-to-effector signaling through G proteins: roles for βγ dimers as well as α-subunits. Cell 71:1069-1072.
4. Braddock, M., and A. Quinn. 2004. Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention. Nat. Rev. Drug Discov. 3:330-339.
5. Brancho, D., N. Tanaka, A. Jaeschke, J. J. Ventura, N. Kelkar, Y. Tanaka, M. Kyuuma, T. Takeshita, R. A. Flavell, R. J. Davis. 2003. Mechanism of p38 MAP kinase activation in vivo. Genes Dev. 17:1969-1978.
6. Cao, W., K. W. Daniel, J. Robidoux, P. Puigserver, A. V. Medvedev, X. Bai, L. M. Floering, B. M. Spiegelman, and S. Collins. 2004. p38 mitogen-activated protein kinase is the central regulator of cyclic AMP-dependent transcription of the brown fat uncoupling protein 1 gene. Mol. Cell. Biol. 24:3057-3067.
7. Carter, A. B., K. L. Knudston, M. M. Monick, and G. W. Hunninghake. 1999. The p38 mitogen-activated protein kinase is required for NF-κB-dependent gene expression: the role of TATA binding protein (TBP). J. Biol. Chem. 274:30858-30863.
8. Glucd, Dynein, and microtubules are specifically required for activation of MKK3/6 and p38 MAPKs. J. Biol. Chem. 279:45308-45311.
9. Choi, S. C., B. S. Kim, M. Y. Song, E. Y. Choi, H. M. Oh, J. H. Lyou, W. C. Han, H. B. Moon, T. H. Kim, J. M. Oh, H. T. Chung, and C. D. Jun. 2003. Downregulation of p38 kinase pathway by cAMP response element-binding protein protects HL-60 cells from iron chelator-induced apoptosis. Free Radic. Biol. Med. 35:1171-1184.
10. Christensen, A. E., F. Selheim, J. de Rooij, S. Dremier, F. Schwede, K. K. Dao, A. Martinez, C. Maenhaut, J. L. Bos, H. G. Genieser, and S. O. Doskeland. 2003. cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J. Biol. Chem. 278:35394-35402.
11. de Groot, R. P., P. J. Coffer, and L. Koenderman. 1998. Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family. Cell Signal. 10:619-628.
12. Derijard, B., J. Raingeaud, T. Barrett, I. H. Wu, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267:682-685.
13. de Rooij, J., F. J. Zwartkruis, M. H. Verheijen, R. H. Cool, S. M. Nijman, A. Wittinghofer, and J. L. Bos. 1998. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396:474-477.
14. Doskeland, S. O., E. Maronde, and B. T. Gjertsen. 1993. The genetic sub-types of cAMP-dependent protein kinase-functionally different or redundant? Biochim. Biophys. Acta 1178:249-258.
15. Epstein, E., A. Sela-Brown, I. Ringel, R. Kilav, S. M. King, S. E. Benashski, J. K. Yisraeli, J. Silver, and T. Naveh-Many. 2000. Dynein light chain binding to a 3′-untranslated sequence mediates parathyroid hormone mRNA association with microtubules. J. Clin. Investig. 105:505-512.
16. Feliciello, A., M. E. Gottesman, and E. V. Avvedimento. 2005. cAMP-PKA signaling to the mitochondria: protein scaffolds, mRNA and phosphatases. Cell Signal. 17:279-287.
17. Feng, W. G., Y. B. Wang, J. S. Zhang, X. Y. Wang, C. L. Li, and Z. L. Chang. 2002. cAMP elevators inhibit LPS-induced IL-12 p40 expression by interfering with phosphorylation of p38 MAPK in murine peritoneal macrophages. Cell Res. 12:331-337.
18. Franco, D. L., M. Nojek, I. L. Molinero, O. A. Coso, and M. A. Costas. 2002. Osmotic stress sensitizes naturally resistant cells to TNF-α-induced apoptosis. Cell Death Differ. 9:1090-1098.
19. Ge, B., H. Gram, F. Di Padova, B. Huang, L. New, R. J. Ulevith, Y. Luo, and J. Han. 2002. MAPKK-independent activation of p38a mediated by TAB1-dependent autophosphorylation of p38a. Science 295:1291-1294.
20. Glass, D. B., H. C. Cheng, L. Mende-Mueller, J. Reed, and D. A. Walsh. 1989. Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor protein. J. Biol. Chem. 264:8802-8810.
21. MAPK and JNK/SAPK pathways are important for induction of nitric-oxide synthase by interleukin-1β in rat glomerular mesangial cells. J. Biol. Chem. 274:36200-36206.
22. Guo, Y. L., B. Kang, J. Han, and J. R. Williamson. 2001. p38β MAP kinase protects rat mesangial cells from TNF-α-induced apoptosis. J. Cell. Biochem. 82:556-565.
23. Han, J., J. D. Lee, L. Bibbs, and R. J. Ulevitch. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-811.
24. Han, J., J. D. Lee, Y. Jiang, Z. Li, L. Feng, and R. J. Ulevitch. 1996. Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J. Biol. Chem. 271:2886-2891.
25. Harada, H., B. Becknell, M. Wilm, M. Mann, L. J. Huang, S. S. Taylor, J. D. Scott, and S. J. Korsmeyer. 1999. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell 3:413-422.
26. Hogarth, D. K., N. Sandbo, S. Taurin, V. Kolenko, J. M. Miano, and N. O. Dulin. 2004. Dual role of PKA in phenotypic modulation of vascular smooth muscle cells by extracellular ATP. Am. J. Physiol. Cell Physiol. 287:C449-CC456.
27. Houslay, M. D., and D. R. Adams. 2003. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem. J. 370:1-18.
28. Huang, S., Y. Jiang, Z. Li, E. Nishida, P. Mathias, S. Lin, R. J. Ulevitch, G. R. Nemerow, and J. Han. 1997. Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b. Immunity 6:739-749.
29. Hsueh, Y. P., and M. Z. Lai. 1995. c-Jun N-terminal kinase but not mitogen-activated protein kinase is sensitive to cAMP inhibition in T lymphocytes. J. Biol. Chem. 270:18094-18098.
30. Impey, S., S. R. McCorkle, H. Cha-Molstad, J. M. Dwyer, G. S. Yochum, J. M. Boss, S. McWeeney, J. J. Dunn, G. Mandel, and R. H. Goodman. 2004. Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell 119:1041-1054.
31. Jaffrey, S. R., and S. H. Snyder. 1996. PIN: an associated protein inhibitor of neuronal nitric oxide synthase. Science 274:774-777.
32. Kaiser, F. J., K. Tavassoli, G. J. Van den Bernd, G. T. Chang, B. Horsthemke, T. Moroy, and H. J. Ludecke. 2003. Nuclear interaction of the dynein light chain LC8a with the TRPS1 transcription factor suppresses the transcriptional repression activity of TRPS1. Hum. Mol. Genet. 12:1349-1358.
33. Karin, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:16483-16486.
34. Karin, M., and A. Lin. 2002. NF-κB at the crossroads of life and death. Nat. Immunol. 3:221-227.
35. Lin, A., A. Minden, H. Martinetto, F. X. Claret, C. Lange-Carter, F. Mercurio, G. L. Johnson, and M. Karin. 1995. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 268:286-290.
36. Lin, A. 2003. Activation of the JNK signaling pathway: breaking the brake on apoptosis. Bioessays 25:1-8.
37. Liu, J., Y. Minemoto, and A. Lin. 2004. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis. Mol. Cell. Biol. 24:10844-10856.
38. Lo, K. W., S. Naishitt, J. S. Fan, M. Sheng, and M. Zhang. 2001. The 8-kDa dynein light chain binds to its targets via a conserved (K/R)XTQT motif. J. Biol. Chem. 276:14059-14066.
39. Lo, K. W., H. M. Kan, L. N. Chan, W. G. Xu, K. P. Wang, Z. Wu, M. Sheng, and M. Zhang. 2005. The 8-kDa dynein light chain binds to p53-binding protein 1 and mediates DNA damage-induced p53 nuclear accumulation. J. Biol. Chem. 280:8172-8179.
40. Lu, X., S. Nemoto, and A. Lin. 1997. Identification of e-Jun NH2-terminal protein kinase (JNK)-activating kinase 2 as an activator of JNK but not p38. J. Biol. Chem. 272:24751-24754.
41. Lubran, M. M. 1988. Bacterial toxins. Ann. Clin. Lab. Sci. 18:58-71.
42. Luschen, S., G. Scherer, S. Ussat, H. Ungefroren, S., and Adam-Klages. 2004. Inhibition of p38 mitogen-activated protein kinase reduces TNF-induced activation of NF-κB, elicits caspase activity, and enhances cytotoxicity. Exp. Cell Res. 293:196-206.
43. Madrid, L. V., M. W. Mayo, J. Y. Reuther, and A. S. Baldwin, Jr. 2001. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κB through utilization of IκB kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 276:18934-18940.
44. Mallik, R., and S. P. Gross. 2004. Molecular motors: strategies to get along. Curr. Biol. 14:R971-R982.
45. Mayr, B., and M. Montminy. 2001. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2:599-609.
46. Muñiz, M., M. E. Martín, J. Hidalgo, and A. Velasco. 1997. Protein kinase A activity is required for the budding of constitutive transport vesicles from the trans-Golgi network. Proc. Natl. Acad. Sci. USA 94:14461-14466.
47. Navarro, C., H. Puthalakath, J. M. Adams, A. Strasser, and R. Lehmann. 2004. Egalitarian binds dynein light chain to establish oocyte polarity and maintain oocyte fate. Nat. Cell Biol. 6:427-435.
48. Nemoto, S., Z. Sheng, and A. Lin. 1998. Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy. Mol. Cell. Biol. 18:3518-3526.
49. + double-positive thymocytes. J. Immunol. 164:1689-1694.
50. Puthalakath, H., D. C. Huang, L. A. O'Reilly, S. M. King, and A. Strasser. 1999. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol. Cell 3:287-296.
51. Rahman, A., K. N. Anwar, M. Minhajuddin, K. M. Bijli, K. Javai, A. L. True, and A. B. Malik. 2004. cAMP targeting of p38 MAP kinase inhibits thrombin-induced NF-κB activation and ICAM-1 expression in endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 287:L1017-L1024.
52. Rao, G. N., and M. S. Runge. 1996. Cyclic AMP inhibition of thrombin-induced growth in vascular smooth muscle cells correlates with decreased JNK1 activity and c-Jun expression. J. Biol. Chem. 271:20805-20810.
53. Rayala, S. K., P. den Hollander, S. Balasenthil, Z. Yang, R. R. Broaddus, and R. Kumar. 2005. Functional regulation of oestrogen receptor pathway by the dynein light chain 1. EMBO Rep. 6:538-544.
54. Robidoux, J., W. Cao, H. Quan, K. W. Daniel, F. Moukdar, X. Bai, L. M. Floering, and S. Collins. 2005. Selective activation of mitogen-activated protein (MAP) kinase kinase 3 and p38a MAP kinase is essential for cyclic AMP-dependent UCP1 expression in adipocytes. Mol. Cell. Biol. 25:5466-5479.
55. Roulston, A., C. Reinhard, P. Amiri, and L. T. Williams. 1998. Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor α. J. Biol. Chem. 273:10232-10239.
56. Rouse, J., P. Cohen, S. Trigon, M. Morange, A. Alonso-Llamazares, D. Zamanillo, T. Hunt, and A. R. Nebreda. 1994. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78:1027-1037.
57. Schnorrer, F., K. Bohmann, and C. Nusslein-Volhard. 2000. The molecular motor dynein is involved in targeting swallow and bicoid RNA to the anterior pole of Drosophila oocytes. Nat. Cell Biol. 2:185-190.
58. Schroer, T. A. 2004. Dynactin. Annu. Rev. Cell Dev. Biol. 20:759-779.
59. Seamon, K. B., W. Padgett, and J. W. Daly. 1981. Forskolin: unique diterpene activator of adenylate cyelase in membranes and in intact cells. Proc. Natl. Acad. Sci. USA 78:3363-3367.
60. Smith, P. G., F. Wang, K. N. Wilkinson, K. J. Savage, U. Klein, D. S. Neuberg, G. Bollag, M. A. Shipp, and R. C. Aguiar. 2005. The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT-dependent apoptosis in diffuse large B-cell lymphoma. Blood 105:308-316.
61. Springett, G. M., H. Kawasaki, and D. R. Spriggs. 2004. Non-kinase second-messenger signaling: new pathways with new promise. Bioessays 26:730-738.
62. Stork, P. J., and J. M. Schmitt. 2002. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 12:258-266.
63. Sunahara, R. K., and R. Taussig. 2002. Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. Mol. Interv. 2:168-184.
64. Tang, F., G. Tang, J. Xiang, Q. Dai, M. R. Rosner, and A. Lin. 2002. Absence of NF-κB-mediated inhibition of c-Jun N-terminal kinase activation contributes to tumor necrosis factor alpha-induced apoptosis. Mol. Cell. Biol. 22; 8571-8579.
65. Tang, G., Y. Minemoto, B. Dibling, N. H. Purcell, Z. Li, M. Karin, and A. Lin. 2001. Inhibition of JNK activation through NF-κB target genes. Nature 414:313-317.
66. Tang, G., J. Yang, Y. Minemoto, and A. Lin. 2001. Blocking caspase-3-mediated proteolysis of IKKβ suppresses TNF-α-induced apoptosis. Mol. Cell 8:1005-1016.
67. Vadlamudi, R. K., R. Bagheri-Yarmand, Z. Yang, S. Balasenthil, D. Nguyen, A. A. Sahin, P. den Hollander, and R. Kumar. 2004. Dynein light chain 1, a p21-activated kinase 1-interacting substrate, promotes cancerous phenotypes. Cancer Cell 5:575-585.
68. Varfolomeev, E. E., and A. Ashkenazi. 2004. Tumor necrosis factor: an apoptosis JuNKie? Cell 116:491-497.
69. Varghese, J., S. Chattopadhaya, and A. Sarin. 2001. Inhibition of p38 kinase reveals a TNF-α-mediated, caspase-dependent, apoptotic death pathway in a human myelomonocyte cell line. J. Immunol. 166:6570-6577.
70. Yin, Y., P. D. Allen, L. Jia, M. G. MacEy, S. M. Kelsey, and A. C. Newland. 2000. Constitutive levels of cAMP-dependent protein kinase activity determine sensitivity of human multidrug-resistant leukaemic cell lines to growth inhibition and apoptosis by forskolin and tumour necrosis factor alpha. Br. J. Haematol. 108:565-573.
71. Yin, Y., P. D. Allen, L. Jia, S. M. Kelsey, and A. C. Newland. 2001. 8-C1-adenosine mediated cytotoxicity and sensitization of T-lymphoblastic leukemia cells to TNFα-induced apoptosis is via inactivation of NF-κB. Leuk. Res. 25:423-431.
72. Yu, C., Y. Minemoto, J. Zhang, J. Liu, F. Tang, T. N. Bui, J. Xiang, and A. Lin. 2004. JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Mol. Cell 13:329-340.
73. Zanke, B. R., E. A. Rubie, E. Winnet, J. Chan, S. Randall, M. Parsons, K. Boudreau, M. McInns, M. Yan, D. J. Templeton, and J. R. Woodgett. 1996. Mammalian mitogen-activated protein kinase pathways are regulated through formation of specific kinase-activator complexes. J. Biol. Chem. 271:29876-29881.
74. Zarubin, T., and J. Han. 2005. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15:11-18.
75. Zhang, J., J. Liu, C. Yu, and A. Lin. 2005. BAD Ser128 is not phosphorylated by c-Jun NH2-terminal kinase for promoting apoptosis. Cancer Res. 65:8372-8378.
76. Zhang, X., D. T. Odom, S. H. Koo, M. D. Conkright, G. Canettieri, J. Best, H. Chen, R. Jenner, E. Herbolsheimer, E. Jacobsen, S. Kadam, J. R. Ecker, B. Emerson, J. B. Hogenesch, T. Unterman, R. A. Young, and M. Montminy. 2005. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc. Natl. Acad. Sci. USA 102:4459-4464.